和誉-B(02256):FGFR4抑制剂依帕戈替尼完成全球I期研究扩展阶段美国首例患者给药
Last Update:
11 2 月, 2026
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.